Answer
The metformin component of empagliflozin + metformin may reduce glucose production in the liver by inhibiting gluconeogenesis and glycogenolysis.
Sources for this answer
- Synjardy film coated tabletsBoehringer Ingelheim Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 31Document updated
Sources checked